Price movement over the last 24 hours
Alcon AG vs Super Micro Computer Inc — how do they compare? Alcon AG trades at $66.85 (market cap $32.69B), while Super Micro Computer Inc trades at $27.42 (market cap $16.98B). The key difference: Alcon AG is the larger of the two by market cap, and Alcon AG pays a 0.54% dividend while Super Micro Computer Inc pays none. Which is the better fit depends on your goals.
| ALC | SMCI | |
|---|---|---|
Market Cap | $32.69B | $16.98B |
Sector | Health | Technology |
52-Week High | $92.22 | $60.71 |
52-Week Low | $62.02 | $20.53 |
Enterprise Value | $36.28B | $24.50B |
Dividend Yield | 0.54% | — |
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Super Micro Computer (SMCI) trades at $27.19, down 0.11% with bearish technical signals. The stock faces headwinds from a Taiwan probe into alleged AI chip smuggling, contributing to recent volatility. Fundamentally, SMCI shows strong revenue growth with $22B in 2025 and $33.7B projected for 2026, though profit margins compressed from 4.77% to 3.7%. Valuation appears attractive with P/E of 14.31 and P/S of 0.54, while recent earnings beat expectations in two of the last three quarters.
The outlook remains cautious due to regulatory risks and negative technical momentum. Analyst consensus is mixed with 36% buy ratings and a $36.43 price target suggesting 34% upside. Key risks include the ongoing Taiwan investigation, competitive pressures in AI infrastructure, and cash flow volatility with projected negative operating cash flow in 2026. The stock presents a value opportunity but requires careful risk management.
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →